
IRadimed Corporation
- Jurisdiction
United States - LEI
549300YVHWP0YJ1YW816 - ISIN
US46266A1097 (IRMD )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€66.22M - Gross margin
77.0% - EBIT
€20.31M - EBIT margin
30.7% - Net income
€17.62M - Net margin
26.6%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
$0.17 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
39.3%
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
ALLEN MONTY K | N/A |
|
|
|
|
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: August 1, 2025 (Q2 2025)